Breaking News, Promotions & Moves

ABL Names Stephanie Colloud GM and COO in Europe

Will oversee operations at the Lyon and Strasbourg development and clinical production sites, leading a team of 160 staff.

ABL, a contract development and manufacturing organization (CDMO) with specialized expertise in the development and manufacturing of solutions for biopharma, appointed Stéphanie Colloud as general manager and chief operating officer (COO) for Europe. In her new role, Colloud will be responsible for operations at the Lyon and Strasbourg development and clinical production sites, leading a team of 160 staff. Colloud’s priorities include strengthening ABL’s R&D work in its GMP production ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters